News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademySponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Webcasts

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Webcasts
  • Subscribe
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
CNS Drug Development Resources|
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos
Advertisement

Lisa Danzig M.D.

Advertisement

Articles by Lisa Danzig M.D.

fig1.png

Comparing Risk Based Monitoring and Remote Trial Management vs. SDV

ByPenelope Manasco M.D.,Michelle Pallas,Lisa Danzig M.D.,Charlene Kimmel,Sean Bennett M.D., Ph.D.,Garrett Manasco,Deborah Thompson MPH,Lisa Bedell MA,Everett Lambeth,Kevin Fielman Ph.D.
September 28th 2018

A new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.

Advertisement

Latest Updated Articles

  • fig1.png
    Comparing Risk Based Monitoring and Remote Trial Management vs. SDV

    Published: September 28th 2018 | Updated:



Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg

2

Using AI and Tokenized Data to Match Patients to Protocols

3

Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity

4

ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation

5

ACT Brief: Designing Feasible Protocols and Breakthroughs in Obesity and Metabolic Research

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us